ddrg/super_eurlex huggingface dataset:
Prior notification of a concentration

(Case M.10389 – PAI Partners/Pasubio)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 390/08)

1. On 17 September 2021, the Commission received notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — PAI Partners (France), — Pasubio (Italy). PAI Partners acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Pasubio. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for PAI Partners: managing and/or advising dedicated private equity funds, which acquire majority participations in companies active in different industry sectors, such as business services, food and consumer goods, general industrials, healthcare and retail & distribution; — for Pasubio: tanning of leather and the production of finished leather products for use in various sectors, including automotive interiors, furniture and luxury goods.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10389 – PAI Partners/Pasubio Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.10419 – Brookfield/Telia Company/Telia Towers)

(Text with EEA relevance)

(2021/C 403/02)

On 28 September 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10419. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10486 — CDPQ/Centerbridge/Medical Solutions)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 398/13)

1. On 22 September 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Caisse de dépôt et placement du Québec (‘CDPQ’, Canada), — Centerbridge Partners, L.P. (‘Centerbridge’, USA), — Medical Solutions LLC (‘Medical Solutions’, USA). CDPQ and Centerbridge acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Medical Solutions. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for CDPQ: globally active long-term institutional investor managing funds primarily for public and para-public pension and insurance plans, — for Centerbridge: global investment management firm active across investment disciplines from private equity to credit and related strategies, and real estate, — for Medical Solutions: staffing agency specialising in placing registered nurses, allied healthcare professionals, interim clinical leaders, and non-clinical professionals.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: Case M.10486 — CDPQ/Centerbridge/Medical Solutions Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10487 — CDPQ/Investcorp/ICR)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 414/05)

1. On 1 October 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Caisse de dépôt et placement de Québec (‘CDPQ’, Canada), — Investcorp Holdings B.S.C. (‘Investcorp’, Kingdom of Bahrain), — ICR OPCO, LLC (‘ICR’, USA). CDPQ and Investcorp acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of ICR. The concentration is accomplished by way of purchase of securities.

2. The business activities of the undertakings concerned are: — for CDPQ: long-term institutional investor managing funds primarily for public and parapublic pension and insurance plans. It invests these funds globally in major financial markets, private equity, infrastructure, and real estate, — for Investcorp: international financial institution acting as a principal and as an intermediary in international investment transactions, — for ICR: strategic communication and advise, specialized in investor relations, public relations, crisis and special situations communications, digital branding, and capital advisory solutions.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10487 — CDPQ/Investcorp/ICR Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.10216 – DFDS/HSF Logistics Group)

(Text with EEA relevance)

(2021/C 406/03)

On 6 September 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10216. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10338 – GALILEO/M6/JV)

(Text with EEA relevance)

(2021/C 426/02)

On 14 October 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in French and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10338. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10070 – EUROFIBER/PROXIMUS/JV)

(Text with EEA relevance)

(2021/C 421/01)

On 26 July 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10070. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10139 – DESFA / COPELOUZOU / DEPA / GASLOG / BTG / GASTRADE)

(Text with EEA relevance)

(2021/C 435/05)

1. On 20 October 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Hellenic Gas Transmission System Operator S.A. (‘DESFA’, Greece), — Ms. Asimina-Eleni Copelouzou (‘Ms Copelouzou’, Greece), — DEPA Commercial S.A. (‘DEPA Commercial’, Greece), — GasLog Cyprus Investments Limited (‘GasLog’, Cyrpus), — Bulgartransgaz EAD (‘BTG’, Bulgaria), — GASTRADE Limited Construction and Technical Company of Natural Gas S.A. (‘GASTRADE’, Greece). DESFA, Ms Copelouzou, DEPA Commercial, GasLog and BTG acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of GASTRADE. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for DESFA: owning, operating, maintaining, managing, and developping the Greek high pressure gas transmission network and the Liquefied Natural Gas (‘LNG’) terminal located on Revithoussa island, Greece, — for Ms Copelouzou: an individual who is the founding shareholder of GASTRADE, — for DEPA Commercial: Greece’s major gas supplier engaging in the supply, wholesale and trading of natural gas, — for GasLog: owning, operating and managing LNG vessels, providing support to energy companies in their LNG supply chain, — for BTG: the Bulgarian state-owned operator performing licensed activities of natural gas transmission and storage, — for GASTRADE: owning and developping a LNG facility to be located near Alexandroupolis in Greece.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10139 – DESFA / COPELOUZOU / DEPA / GASLOG / BTG / GASTRADE Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Non-opposition to a notified concentration

(Case M.10443 – ALLIANZ CAPITAL/AIMCO/DALMORE/GENERATION/PORTERBROOK)

(Text with EEA relevance)

(2021/C 432/01)

On 20 October 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10443. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration (Case M.10447 – NN / METLIFE GREECE / METLIFE POLAND) (Text with EEA relevance) (2021/C 453/04)

1. On 29 October 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — NN Group N.V. (‘NN’, the Netherlands), — MetLife Life Insurance S.A. (‘MetLife Greece’, Greece), — MetLife Towarzystwo Ubezpieczeń na Życie i Reasekuracji S.A. (‘MetLife Poland’, Poland). NN acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of MetLife Greece and of MetLife Poland. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — NN: a financial services company listed on the Euronext Amsterdam with a presence in 20 countries, including several European countries and Japan. NN offers retirement services, pensions, insurance, investments, and banking services. NN is inter alia active in Poland, in life insurance (including pensions) and asset management, and in Greece, in the life and health insurance (including pensions), — MetLife Greece: provision of life and health insurance (including pensions) in Greece, — MetLife Poland: provision of life insurance (including pensions) and asset management in Poland.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10447 – NN / METLIFE GREECE / METLIFE POLAND Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Prior notification of a concentration

(Case M.10449 – KIA / ALMAVIVA)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 447/06)

1. On 25 October 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Kuwait Investment Authority (‘KIA’, Kuwait), — Almaviva Capital S.A.S. (‘Almaviva’, France). KIA, through Wren House Infrastructure LP, acquires within the meaning of Article 3(1)(b) of the Merger Regulation indirect sole control of the whole of Almaviva. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for KIA: manages the sovereign wealth funds of the State of Kuwait as a global investor, with investments in all main geographical areas (including the Americas, Europe and Asia-Pacific) and asset classes (including real estate, private and public equity, fixed income and alternative investment markets across the globe), — for Almaviva: head of the Almaviva Group, active in the health sector and in particular operating diagnostics and hospital care services. Almaviva Group is active in France and has a limited activity in Canada.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10449 – KIA / ALMAVIVA Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.10460 – DMK / NIESKY / UELZENA / MILCHTROCKNUNG SÜDHANNOVER)

(Text with EEA relevance)

(2021/C 464/03)

On 4 November 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in German language and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10460. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10478 – CPP INVESTMENTS / BC PARTNERS / CERAMTEC)

(Text with EEA relevance)

(2021/C 461/03)

On 8 November 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10478. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10280 – ABP/Slaney/Linden)

(Text with EEA relevance)

(2021/C 473/03)

On 2 July 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10280. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10424 – FORESTAL ARAUCO / OTPPB / AGRICOLA NEUFUN JV)

(Text with EEA relevance)

(2021/C 472/03)

On 6 October 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10424. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.